2006 Vol.24, N°6 - Suppl.43 - Table of contents

Remission in Rheumatic Diseases

Guest Editors: D. Aletaha, J.S. Smolen, A. Kavanaugh, T. Pincus

Audio summaries of each article may be downloaded directly in MP3 format, or downloaded from AppleiTunes music store.

CME Credit available through Vanderbilt University.

The Journal thanks Abbott, Amgen Inc., Bristol-Myers Squibb, Centocor Inc., Hoffman LaRoche, Novartis Pharmaceuticals Corporation, UCB, Wyeth Pharmaceuticals for support of this Supplement.

pictures and PubMed Link of our Authors.

Webmaster for the Supplement: Andrea Stancati, M.D. Italy

Subscribe to our PodCast for free on iTunes Music Store (need Apple iTunes installed) or download the audio files in .mp3 format.

purchase complete issue

Introduction

CER2865
2006,24,6,Suppl.43
Pg. 0001-0006

Free to view

Complexities in defining remission in rheumatic diseases
T. Pincus, A. Kavanaugh, D. Aletaha, J. Smolen

Remission in rheumatoid arthritis

CER2866
2006,24,6,Suppl.43
Pg. 0007-0013

Free to view

What should be our treatment goal in rheumatoid arthritis today?
J.S. Smolen, D. Aletaha

CER2867
2006,24,6,Suppl.43
Pg. 0014-0021

Free to view

ACR remission criteria and response criteria
V. K. Ranganath, D. Khanna, H. E. Paulus

CER2868
2006,24,6,Suppl.43
Pg. 0022-0028

Free to view

Definitions of remission for rheumatoid arthritis and review of selected clinical cohorts and randomised clinical trials for the rate of remission
H. Mäkinen, P. Hannonen, T. Sokka

CER2869
2006,24,6,Suppl.43
Pg. 0029-0032

Free to view

DAS remission cut points
J. Fransen, P.L.C.M. van Riel

CER2870
2006,24,6,Suppl.43
Pg. 0033-0036

Free to view

Can remission be maintained with or without further drug therapy in rheumatoid arthritis?
B. Saleem, S. Nizam, P. Emery

CER2871
2006,24,6,Suppl.43
Pg. 0037-0040

Free to view

Remission and radiographic progression in rheumatoid arthritis
A.E. Voskuyl, B.A.C. Dijkmans

CER2872
2006,24,6,Suppl.43
Pg. 0041-0044

Free to view

Is remission in rheumatoid arthritis associated with radiographic healing?
R. Rau

Alternatives to strict remission in RA

CER2873
2006,24,6,Suppl.43
Pg. 0045-0051

Free to view

Remission of rheumatoid arthritis: should we care about definitions?
D. Aletaha, J.S. Smolen

CER2874
2006,24,6,Suppl.43
Pg. 0052-0059

Free to view

Low disease activity state in rheumatoid arthritis: concepts and derivation of minimal disease activity
G. Wells, M. Boers, P. Tugwell

CER2875
2006,24,6,Suppl.43
Pg. 0060-0073

Free to view

A proposed approach to recognise “near-remission” quantitatively without formal joint counts or laboratory tests: a patient self-report questionnaire routine assessment of patient index data (RAPID) score as a guide to a “continuous quality improvement” s
T. Pincus, Y. Yazici, M. Bergman, C. Swearingen, T. Harrington

Clinical trials and other studies in which low disease activity or remission has been used as an end

CER2876
2006,24,6,Suppl.43
Pg. 0074-0076

Free to view

Remission as the treatment goal – the FIN-RACo trial
T. Sokka, H. Mäkinen, K. Puolakka, T. Möttönen, P. Hannonen

CER2877
2006,24,6,Suppl.43
Pg. 0077-0082

Free to view

Aiming at low disease activity in rheumatoid arthritis with initial combination therapy or initial monotherapy strategies: the BeSt study
C.F. Allaart, Y.P.M. Goekoop-Ruiterman, J.K. de Vries-Bouwstra, F.C. Breedveld, B.A.C. Dijkmans, FARR study group

Remission in rheumatic diseases other than RA

CER2878
2006,24,6,Suppl.43
Pg. 0083-0087

Free to view

Defining remission in psoriatic arthritis
A. Kavanaugh, J. Fransen

CER2879
2006,24,6,Suppl.43
Pg. 0088-0092

Free to view

Remission in ankylosing spondylitis
J. Zochling, J. Braun

CER2880
2006,24,6,Suppl.43
Pg. 0093-0098

Free to view

Remission in antineutrophil cytoplasmic antibody-associated systemic vasculitis
C. Mukhtyar, B. Hellmich, D. Jayne, O. Flossmann, R. Luqmani

CER2881
2006,24,6,Suppl.43
Pg. 0099-0104

Free to view

Assessing remission in systemic lupus erythematosus
M. Mosca, S. Bombardieri

CER2882
2006,24,6,Suppl.43
Pg. 0105-0110

Free to view

Remission in juvenile idiopathic arthritis
A. Ravelli, A. Martini

Continuing Medical Education Activity

CER2883
2006,24,6,Suppl.43
Pg. 0111-0120

Free to view

Clinical and Experimental Rheumatology: Remission in Rheumatic Diseases
***

This journal-based Continuing Medical Education (CME) activity has bee jointly sponsored by Vanderbilt University School of Medicine and Abbott Immunology, Amgen Inc., .Bristol-Myers Squibb, Centocor Inc., Genentech, Novartis Pharmaceuticals Corporation, Pfizer Inc., Wyeth Pharmaceuticals.

This issue is valid for obtaining a maximum of 20 category 1 credits toward the AMA Physician's Recognition Award. Each article has been certified for 0.5 category 1 credit. Each physician should claim only those credits that he/she actually spent in the activity.

To receive the CME credit, for US physicians, please go to page S208-S221